ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,511.40
-0.11%
S&P ASX All Technology
4,034.50
0.55%
Brent Oil
74.565
0.00%
US Dollar vs AUD
1.5949
0.00%
Bitcoin
96,685.11
0.14%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Talphera Inc (TLPH)

  7. Talphera Inc (TLPH) News

TLPH

Talphera (TLPH)

Talphera Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLPH
DateTimeSourceHeadlineSymbolCompany
15/01/202500:30PR Newswire (US)Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT StudyNASDAQ:TLPHTalphera Inc
12/12/202408:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLPHTalphera Inc
06/12/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
03/12/202408:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
03/12/202408:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
03/12/202404:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TLPHTalphera Inc
30/11/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLPHTalphera Inc
25/11/202411:27PR Newswire (US)Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive DirectorsNASDAQ:TLPHTalphera Inc
14/11/202409:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLPHTalphera Inc
14/11/202408:05PR Newswire (US)Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TLPHTalphera Inc
07/11/202408:05PR Newswire (US)Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024NASDAQ:TLPHTalphera Inc
11/10/202407:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
09/10/202407:54PR Newswire (US)Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual SummitNASDAQ:TLPHTalphera Inc
02/10/202407:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLPHTalphera Inc
06/09/202406:15PR Newswire (US)Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TLPHTalphera Inc
04/09/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
19/08/202422:30PR Newswire (US)Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal CircuitNASDAQ:TLPHTalphera Inc
15/08/202407:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLPHTalphera Inc
15/08/202406:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLPHTalphera Inc
15/08/202406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLPHTalphera Inc
15/08/202406:01PR Newswire (US)Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TLPHTalphera Inc
06/08/202406:05PR Newswire (US)Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024NASDAQ:TLPHTalphera Inc
15/06/202407:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLPHTalphera Inc
21/05/202407:25PR Newswire (US)Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TLPHTalphera Inc
21/05/202407:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLPHTalphera Inc
17/05/202407:45PR Newswire (US)Talphera to Participate at A.G.P. Virtual Healthcare ConferenceNASDAQ:TLPHTalphera Inc
15/05/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLPHTalphera Inc
15/05/202406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLPHTalphera Inc
15/05/202406:05PR Newswire (US)Talphera Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TLPHTalphera Inc
03/05/202406:15PR Newswire (US)Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024NASDAQ:TLPHTalphera Inc
 Showing the most relevant articles for your search:NASDAQ:TLPH

Your Recent History

COIN
DOGEUSD
Dogecoin
ASX
CSL
CSL
ASX
QBE
QBE Insurance
NYSE
MCD
McDonalds
ASX
XJO
S&P ASX 200
ASX
XFL
S&P ASX 50
ASX
NCM
Newcrest Mining
ASX
NAB
National Australia Bank
NYSE
NKE
Nike
COIN
AVAXUSD
Avalanche
FX
EURAUD
Euro vs AUD
NASDAQ
NVDA
NVIDIA
ASX
BHP
BHP
ASX
AMP
AMP
FX
AUDJPY
AUD vs Yen
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads